REED JOHN C 4
4 · JOHNSON & JOHNSON · Filed Oct 20, 2025
Insider Transaction Report
Form 4
REED JOHN C
EVP, Innovative Medicine, R&D
Transactions
- Exercise/Conversion
Employee Stock Options (Right to Buy)
2025-10-17$157.92/sh−21,721$3,430,180→ 43,442 totalExercise: $157.92Exp: 2034-02-15→ Common Stock (21,721 underlying) - Exercise/Conversion
Common Stock
2025-10-17$157.92/sh+21,721$3,430,180→ 32,379 total - Sale
Common Stock
2025-10-17$192.71/sh−21,721$4,185,793→ 10,658 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $192.69 to $192.87. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date.